ImageneBio Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
ImageneBio is a clinical-stage biotechnology company based in San Diego, California, located at 12526 High Bluff Drive, Suite 345, 92130. The company focuses on developing therapeutics for immunological, autoimmune, and inflammatory diseases with differentiated clinical profiles. Its lead program IMG-007 is a receptor-targeting, nondepleting anti-OX40 monoclonal antibody with an extended half-life. IMG-007 has completed Phase 1b/2a trials in atopic dermatitis and alopecia areata and is currently in a Phase 2b trial for moderate-to-severe atopic dermatitis. ImageneBio maintains its information on its website at imagenebio.com.